TTN and Duchenne muscular dystrophy: These findings suggest that the serum titin/Cr ratio in pediatric patients overcomes the limitations posed by age-related changes effects on serum CK levels, thereby emerging as a novel and superior biomarker for differentiating between pediatric DMD and BMD.